Weight-Loss Drug Mounjaro Now Available in India, All You Need to Know
US pharmaceutical giant Eli Lilly has introduced Mounjaro (Tirzepatide) in India, following approval from the Central Drugs Standard Control Organization…
Novo Nordisk
Read More
Eli Lilly’s Mounjaro Overtakes Novo Nordisk’s Wegovy in UK Market Leadership
Eli Lilly’s Mounjaro has emerged as the leading choice in the UK’s private obesity drug market, outperforming Novo Nordisk’s Wegovy…
Novo Nordisk India Urges Early Wegovy Launch Amid Competition Concerns
Novo Nordisk’s team in India is asking the company’s global leaders to launch its weight-loss drug Wegovy earlier than planned….
- 1
- 2